Pediatric Heart Transplantation in Human Leukocyte Antigen–Sensitized Patients | Zendy

Stacey M. PollockBarZiv | Zendy; Neal den Hollander | Zendy; BoYee Ngan | Zendy; Paul F. Kantor | Zendy; Brian W. McCrindle | Zendy; Lori J. West | Zendy; Anne I. Dipchand | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pediatric Heart Transplantation in Human Leukocyte Antigen–Sensitized Patients

Author(s) -

Stacey M. PollockBarZiv,

Neal den Hollander,

BoYee Ngan,

Paul F. Kantor,

Brian W. McCrindle,

Lori J. West,

Anne I. Dipchand

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.709022

Subject(s) - medicine , panel reactive antibody , plasmapheresis , thymoglobulin , immunosuppression , rituximab , heart transplantation , tacrolimus , heart disease , transplantation , basiliximab , gastroenterology , surgery , immunology , antibody , kidney transplantation

There is an elevated risk for poor outcomes after heart transplant (HTx) in patients sensitized to human leukocyte antigens including graft dysfunction, acute cellular and antibody-mediated (AMR) rejection, and cardiac allograft vasculopathy. We report our experience with human leukocyte antigens-sensitized pediatric HTx recipients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research